ASB Consultores’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Buy |
644
+70
| +12% | +$28.4K | 0.17% | 105 |
|
|
2025
Q1 | $286K | Sell |
574
-444
| -44% | -$221K | 0.19% | 82 |
|
|
2024
Q4 | $530K | Sell |
1,018
-38
| -4% | -$19.8K | 0.22% | 70 |
|
|
2024
Q3 | $653K | Buy |
1,056
+271
| +35% | +$168K | 0.26% | 61 |
|
|
2024
Q2 | $434K | Sell |
785
-152
| -16% | -$84.1K | 0.16% | 88 |
|
|
2024
Q1 | $545K | Buy |
+937
| New | +$545K | 0.14% | 108 |
|
|
2023
Q4 | – | Sell |
-445
| Closed | -$225K | – | 159 |
|
|
2023
Q3 | $225K | Sell |
445
-247
| -36% | -$125K | 0.09% | 119 |
|
|
2023
Q2 | $361K | Sell |
692
-88
| -11% | -$45.9K | 0.18% | 116 |
|
|
2023
Q1 | $450K | Buy |
780
+165
| +27% | +$95.1K | 0.18% | 83 |
|
|
2022
Q4 | $339K | Sell |
615
-296
| -32% | -$163K | 0.14% | 111 |
|
|
2022
Q3 | $462K | Buy |
911
+531
| +140% | +$269K | 0.22% | 58 |
|
|
2022
Q2 | $206K | Sell |
380
-898
| -70% | -$487K | 0.09% | 167 |
|
|
2022
Q1 | $755K | Buy |
1,278
+388
| +44% | +$229K | 0.32% | 44 |
|
|
2021
Q4 | $594K | Buy |
+890
| New | +$594K | 0.29% | 66 |
|